SCHEMBL14729758

SCHEMBL14729758

Nc1ccc(Nc2nc(N3CCCCCC3)nc3cn[nH]c(=O)c23)cc1

nearest known ligand 0.77

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 19/20 0.77
JAK2 O60674 7/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30604811 0.91 SYK (0.88) SYKJAK2
SCHEMBL26389942 0.91 SYK (0.88) SYKJAK2
SCHEMBL18930353 0.90 SYK (0.78) SYKJAK2
SCHEMBL29635112 0.90 SYK (0.76) SYKJAK2
SCHEMBL14717004 0.90 SYK (0.76) SYKJAK2
SCHEMBL14716847 0.87 SYK (1.00) SYKJAK2
SCHEMBL20376711 0.87 SYK (0.74) SYKJAK2
SCHEMBL30604892 0.87 SYK (1.00) SYKJAK2
SCHEMBL14717145 0.86 SYK (0.84) SYKJAK2
SCHEMBL20376660 0.86 JAK2 (0.77) SYKJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017095898-A1 USES OF PYRIMIDO-PYRIMIDAZINONES TO TREAT CANCER ASANA BIOSCIENCES, LLC (US) 2017-06-08 WO disclosed
WO-2013028818-A1 PYRIMIDO- PYRIDAZINONE COMPOUNDS AND USE THEREOF ENDO PHARMACEUTICALS INC. (US) 2013-02-28 WO disclosed